Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 24, 2016

View Archived Issues

Allergan completes acquisition of Chase Pharmaceuticals

Viral Gene announces phase II funding for novel vaccine to prevent colon cancer metastases

Juno Therapeutics places clinical hold on phase II ROCKET trial of JCAR-015

Proteros and Merck Sharp & Dohme sign second oncology collaboration on epigenetic target

SM-04755 demonstrates promise in models of psoriasis, chronic tendinopathy and scleroderma

LPA receptor 1 as a target for diabetic nephropathy

Pfizer patents myeloperoxidase irreversible inhibitors

Genentech and Roche disclose retinoid RORgamma receptor ligands

Pfizer describes JAK inhibitors

Rayaldee set for U.S. launch

Sun Pharma signs definitive agreement to acquire JSC Biosintez

Sanofi Pasteur MSD vaccines joint venture to end next month

PRX-OTC from PhaseRx receives FDA orphan drug designation

European Commission grants conditional marketing authorization for Ninlaro

Institute of Human Virology announces grants and new international center to tackle HIV/AIDS

Navidea signs Lymphoseek asset purchase agreement with Cardinal Health

FDA grants orphan drug designation to ABTL-0812 for the treatment of pancreatic cancer

NeuroSearch outlines plan for remaining assets after Danish Supreme Court decision

Filgotinib begins phase III trial in Crohn's disease

C3c may be useful to monitor psoriatic arthritis

Arsanis initiates phase II trial of ASN-100 to prevent S. aureus pneumonia

RGC upregulation may have a pathogenic role in lupus nephritis

Xencor initiates phase I study of XmAb-13676 for CD20-expressing hematologic malignancies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...